durolane
-
Biologics
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Biologics
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
September 22, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing…
Read More » -
Biologics
Bioventus Selects Bazis NN as Distributor of DUROLANE® in Russia
June 15, 2020 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has selected Bazis NN as its authorized distributor for DUROLANE,…
Read More » -
Biologics
Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans
September 09, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…
Read More » -
Biologics
Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL)
August 12, 2019 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE SJ (1mL), and has received…
Read More » -
Biologics
Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner
January 29, 2019 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA)…
Read More » -
Hospitals
Bioventus Receives ANVISA Approval to Market DUROLANE® in Brazil and Selects Pfizer as Exclusive Distribution Partner
October 02, 2018 HOOFDDORP, Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has received approval from Agência Nacional de Vigilância…
Read More » -
Biologics
Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia
January 17, 2017 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, announced it has selected MEDSERVICE to distribute DUROLANE®…
Read More » -
Biologics
Bioventus Enters Into New Agreement for DUROLANE®
December 14, 2016 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has a new agreement with…
Read More » -
Biologics
Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients
November 14, 2016 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, has entered the patient care market in Mexico.…
Read More » -
Biologics
Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan
HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, today announced its entry into the patient care market in Taiwan…
Read More »